- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00826657
Vitamin B12 Supplementation Study
May 19, 2015 updated by: USDA, Western Human Nutrition Research Center
Assessment of Functional Vitamin B12 Deficiency in Mexican Women
We hope to learn the clinical and functional signs of sub-clinical vitamin B12 deficiency and its response to supplementation in non-anemic, non-pregnant, and non-lactating women in Rural Mexico.
Vitamin B12 is important in hematopoiesis, neuro-cognitive functions and genetic integrity.
However vitamin B12 is only found in animal source foods therefore a large segment of the population in developing countries and those practicing vegetarianism are at risk of deficiency of the vitamin.
This information will help decide weather supplementation with vitamin B12 is necessary in such populations for public health reasons.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Queretaro, Mexico
- Universidad Autónoma de Querétaro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 59 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women age 20-59, apparently healthy, no severe B12 deficiency
Exclusion Criteria:
- pregnancy, lactation, anemia and disease states
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: placebo
Receive placebo (sugar pill) during the intervention.
Received a 1000 mg vitamin B12 injection at the end of the study.
|
placebo given as a daily supplement 1000 mg injection of vitamin B12 given at the end of the study
Other Names:
|
ACTIVE_COMPARATOR: Vitamin B12
Received 500 micrograms vitamin B12 per day during the study Received a 1000 mg vitamin B12 injection at the start of the study
|
500 microgram daily supplement of vitamin B12 1000 mg injection vitamin B12 given at the start of the study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
response to B12 supplementation in serum B12, Methylmalonic acid, homocystein, and holotranscobalamin concentrations
Time Frame: 0 and 3 mos
|
0 and 3 mos
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
DNA methylation change, and hematological response to B12 supplementation
Time Frame: 0 and 3 mos
|
0 and 3 mos
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2004
Primary Completion (ACTUAL)
August 1, 2005
Study Completion (ACTUAL)
November 1, 2006
Study Registration Dates
First Submitted
January 16, 2009
First Submitted That Met QC Criteria
January 20, 2009
First Posted (ESTIMATE)
January 22, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
May 21, 2015
Last Update Submitted That Met QC Criteria
May 19, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200412519-3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin B12 Deficiency
-
Charite University, Berlin, GermanyCompletedDeficiency, Vitamin | Vegan's Anemia (Vitamin B12 Deficiency) | Deficiencies MicronutrientGermany
-
Texas A&M UniversityUnknownCognitive Change | Nutritional Anemia | Diet, Healthy | Nutrient Deficiency | Diet; Deficiency | Visual Spatial Processing | Dietary Deficiency | Dietary B12 Deficiency | Dietary Zinc Deficiency | Dietary Vitamin B12 Deficiency Anemia | Dietary Deficiency of Selenium and Vitamin EUnited States
-
Liaquat University of Medical & Health SciencesNot yet recruitingVitamin B 12 DeficiencyPakistan
-
University Children's Hospital, ZurichActive, not recruitingVitamin B 12 DeficiencyAustria, Germany
-
University of British ColumbiaDairy Farmers of CanadaCompletedVitamin B 12 DeficiencyCanada
-
Haukeland University HospitalNorwegian Foundation for Health and Rehabilitation; Foundation to Promote Research...CompletedVitamin B 12 DeficiencyNorway
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
James J. Peters Veterans Affairs Medical CenterCompletedMacrocytic Anemia With Vitamin B12 DeficiencyUnited States
-
George Washington UniversityIfakara Health InstituteActive, not recruiting
-
Fu Jen Catholic UniversityCompletedVitamin B 12 DeficiencyTaiwan
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States